Medication Dispenser Authorization With Blockchain Audit Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional medication access systems lack secure, real-time tracking and incentivization mechanisms for opioid use, leading to potential abuse and addiction, with centralized systems vulnerable to manipulation and incomplete audit trails.

Innovation Solution

A blockchain-based system that cryptographically binds authorization to device-attested state, enforces windowed policies, and creates a tamper-evident audit trail using smart contracts and Merkle-authenticated telemetry for secure, decentralized medication management and incentivization.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If a centralized medication access system is used, then ease of operation and centralized control are improved, but security against manipulation and completeness of audit trails deteriorate

Engineering Contradiction:
Improvecentralized controlVSAvoidsecurity against manipulation
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent introduces a blockchain network as an intermediary layer between the medication dispenser and the centralized system. This blockchain intermediary maintains a decentralized, tamper-evident ledger of all medication transactions, preventing manipulation while still allowing centralized authorization through cryptographic proofs. The blockchain acts as a trusted mediator that both parties can verify independently.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system segments the centralized authorization function from the audit trail maintenance function. Centralized authorities can issue cryptographic authorization tokens, but the actual recording and verification of medication dispensing is distributed across multiple blockchain nodes. This segmentation prevents single-point manipulation while maintaining coordinated control.

Inventive Principle:
Principle #1Segmentation

2Reliability

If real-time tracking and authorization binding are implemented, then medication security and abuse prevention are improved, but system complexity and computational requirements increase

Engineering Contradiction:
Improvemedication securityVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The medication dispenser is equipped with cryptographic capabilities to self-verify authorization tokens and self-record transactions on the blockchain without requiring complex external verification systems. The device autonomously binds authorization to device-attested state through local cryptographic operations, reducing the need for complex centralized verification infrastructure.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent replaces complex mechanical and procedural authorization verification mechanisms with cryptographic proofs and blockchain consensus. Instead of layered human verification and physical security measures, the system uses mathematical cryptography to provide simpler, more reliable authorization binding and tracking.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Loss of time

If extended-release opioid dosage forms are used, then dosing frequency is reduced, but risk of abuse and addiction increases

Engineering Contradiction:
Improvedosing frequencyVSAvoidabuse risk
Core Design Contradiction:
Loss of timeVSObject-affected harmful factors

Solution Approach 1:

The system implements real-time feedback loops where the blockchain network continuously monitors medication dispensing patterns, authorization validity, and device integrity. When anomalies are detected (such as unauthorized access attempts or unusual dispensing patterns), the system can trigger alerts to healthcare providers or automatically suspend authorization, providing continuous feedback to prevent abuse.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system performs preliminary cryptographic verification of authorization tokens and device state before allowing medication dispensing. By binding authorization to specific device-attested states and verifying these conditions in advance, the system prevents unauthorized access before it can occur, rather than relying solely on post-detection measures.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20260080997A1Blockchain based system and method for regulation and incentivizing medication management
Publication Date: 2026.03.19 CHOUDHURY SAMBHU N
  • US20260080997A1 patent drawing
  • US20260080997A1 patent drawing
  • US20260080997A1 patent drawing

AI summary

A system and methods for medication management and incentivized compliance using a distributed ledger are disclosed. A medication dispenser with a lock, weight sensor, and control unit communicates with a blockchain network executing smart contracts that authorize dispensing events, record authenticated telemetry, and account for tokenized dose entitlements normalized in morphine-milligram equivalents (MME). A prescriber device assigns entitlements to a patient wallet; the dispenser unlocks only upon receipt of an on-chain authorization event that cryptographically binds the requested dose to measured inventory and policy constraints. Post-dispense, signed weight deltas are committed to an authenticated store for audit. Optional risk scoring derived from historical usage features gates dispensing or escalates to multi-party authorization. Unused entitlements may be reconciled under policy via redemption logic. The architecture reduces diversion by coupling cryptographic authorization with tamper-evident telemetry and immutable audit trails.